Your browser doesn't support javascript.
loading
Larotrectinib Treatment for Patients With TRK Fusion-Positive Salivary Gland Cancers.
Le, Xiuning; Baik, Christina; Bauman, Jessica; Gilbert, Jill; Brose, Marcia S; Grilley-Olson, Juneko E; Patil, Tejas; McDermott, Ray; Raez, Luis E; Johnson, Jennifer M; Shen, Lin; Tahara, Makoto; Ho, Alan L; Norenberg, Ricarda; Dima, Laura; Brega, Nicoletta; Drilon, Alexander; Hong, David S.
Afiliação
  • Le X; University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Baik C; University of Washington/Seattle Cancer Care Alliance, Seattle, WA, USA.
  • Bauman J; Department of Hematology/Oncology, Fox Chase Cancer Center, Philadelphia, PA, USA.
  • Gilbert J; Vanderbilt University, Nashville, TN, USA.
  • Brose MS; Sidney Kimmel Cancer Center of Jefferson University Health, Philadelphia, PA, USA.
  • Grilley-Olson JE; University of North Carolina Lineberger Cancer Center, Chapel Hill, NC, USA.
  • Patil T; Department of Medicine, Division of Medical Oncology, University of Colorado, Denver, Aurora, CO, USA.
  • McDermott R; St. Vincent's University Hospital, Dublin, Ireland.
  • Raez LE; Cancer Trials Ireland, Dublin, Ireland.
  • Johnson JM; Memorial Cancer Institute, Florida International University, Miami, FL, USA.
  • Shen L; Sidney Kimmel Cancer Center of Jefferson University Health, Philadelphia, PA, USA.
  • Tahara M; Department of Gastrointestinal Oncology, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Peking University Cancer Hospital and Institute, Beijing, China.
  • Ho AL; National Cancer Center Hospital East, Kashiwa, Japan.
  • Norenberg R; Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Dima L; Weill Cornell Medical College, New York, NY, USA.
  • Brega N; Chrestos Concept GmbH & Co. KG, Essen, Germany.
  • Drilon A; Bayer HealthCare Pharmaceuticals, Inc., Basel, Switzerland.
  • Hong DS; Bayer S.p.A., Milan, Italy.
Oncologist ; 2022 May 10.
Article em En | MEDLINE | ID: mdl-35536733

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Oncologist Assunto da revista: NEOPLASIAS Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Oncologist Assunto da revista: NEOPLASIAS Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos